Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells

被引：5
|
作者：
Adkar, Shaunak S. [1 ]
Willard, Vincent P. [1 ]
Brunger, Jonathan M. [1 ]
Shiao, Kenneth T. [1 ]
Gersbach, Charles A. [1 ]
Guilak, Farshid [1 ,2 ,3 ]
机构：
[1] Duke Univ, Durham, NC USA
[2] Washington Univ, St Louis, MO USA
[3] Shriners Hosp Children, St Louis, MO USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33127-6
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
318
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [41] Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease
    Jung, Juwon
    Hwang, Sunsook
    Seol, Hyewon
    Kim, A-Hyeon
    Lee, Ha Myoung
    Sung, Jin Jea
    Jeong, Seung Min
    Choi, Young Min
    Jun, Jong Kwan
    Kim, Dong-wook
    Jang, Jiho
    STEM CELL RESEARCH, 2021, 53
  • [42] A Small Molecule Enhanced CRISPR/Cas9 Methodology for Genome Editing of Dog (Canis familiaris) induced Pluripotent Stem Cells (diPSC)
    Federico, Francesca
    Federico, Niksha
    Sternik, Gabriel
    Federico, Tessya
    Esmaeli-Azad, Babak
    FASEB JOURNAL, 2016, 30
  • [43] Targeted knock-in into the OVA locus of chicken cells using CRISPR/Cas9 system with homology-independent targeted integration
    Shi, Ming
    Kawabe, Yoshinori
    Ito, Akira
    Kamihira, Masamichi
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2020, 129 (03) : 363 - 370
  • [44] CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues
    Brunger, Jonathan M.
    Zutshi, Ananya
    Willard, Vincent P.
    Gersbach, Charles A.
    Guilak, Farshid
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (05) : 1111 - 1121
  • [45] CRISPR/Cas9 Genome Editing to Repair Receptor-Mediated Endocytosis in Homozygous Familial Hypercholesterolemia Induced Pluripotent Stem Cells
    Omer, Linda
    Hudson, Elizabeth A.
    Hoying, Jay B.
    Boyd, Nolan L.
    FASEB JOURNAL, 2017, 31
  • [46] Developing Gene Therapies for Inherited Retinal Dystrophies Using CRISPR/Cas9 Genomic Editing and Human Pluripotent Stem Cells
    Abdeen, Amr
    Steyer, Benjamin
    Carlson-Stevermer, Jared
    Chen, Guojun
    Wang, Yuyuan
    Xie, Ruosen
    Shahi, Pawan
    Sinha, Divya
    Gamm, David
    Pattnaik, Bikash
    Gong, Shaoqin
    Saha, Kris
    MOLECULAR THERAPY, 2019, 27 (04) : 255 - 255
  • [47] Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
    Schumann, Kathrin
    Lin, Steven
    Boyer, Eric
    Simeonov, Dimitre R.
    Subramaniam, Meena
    Gate, Rachel E.
    Haliburton, Genevieve E.
    Yee, Chun J.
    Bluestone, Jeffrey A.
    Doudna, Jennifer A.
    Marson, Alexander
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (33) : 10437 - 10442
  • [48] Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology
    Esteve, Julie
    Blouin, Jean-Marc
    Lalanne, Magalie
    Azzi-Martin, Lamia
    Dubus, Pierre
    Bidet, Audrey
    Harambat, Jerome
    Llanas, Brigitte
    Moranvillier, Isabelle
    Bedel, Aurelie
    Moreau-Gaudry, Francois
    Richard, Emmanuel
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 517 (04) : 677 - 683
  • [49] Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss
    Stojkovic, Miodrag
    Han, Dongjun
    Jeong, Minjin
    Stojkovic, Petra
    Stankovic, Konstantina M.
    STEM CELLS, 2021, 39 (06) : 673 - 696
  • [50] Testing the utility of CRISPR/Cas9 genome editing tools for genetic screens and genome editing in human cells
    San Juan, I. Guerra
    Steele, J. W.
    Cambray, S.
    Dizon, J.
    Lotfy, P.
    Almenar, A.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
12345